Vertebrobasilar Thrombolysis with Intravenous Tirofiban: Case Report
Copyright policy )Vertebrobasilar Thrombolysis with Intravenous Tirofiban: Case Report
The use of thrombolytic agents in the setting of established cerebral infarction is limited by concerns for hemorrhagic transformation. Novel thrombolytic approaches, which have received minimal consideration, may be associated with lower risks of hemorrhage. We illustrate vertebrobasilar thrombolysis with intravenous tirofiban, a selective platelet glycoprotein IIb/IIIa receptor antagonist, and discuss the potential thrombolytic properties of this class of antithrombotics.
- University of Pennsylvania United States
Male, Arterial Occlusive Diseases, Hemorrhage, Platelet Glycoprotein GPIIb-IIIa Complex, Stroke, Treatment Outcome, Fibrinolytic Agents, Tirofiban, Vertebrobasilar Insufficiency, Humans, Tyrosine, Thrombolytic Therapy, Platelet Aggregation Inhibitors, Aged
Male, Arterial Occlusive Diseases, Hemorrhage, Platelet Glycoprotein GPIIb-IIIa Complex, Stroke, Treatment Outcome, Fibrinolytic Agents, Tirofiban, Vertebrobasilar Insufficiency, Humans, Tyrosine, Thrombolytic Therapy, Platelet Aggregation Inhibitors, Aged
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).7 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!